[Hairy cell leukemia successfully treated with deoxycoformycin]. 1992

A Matsuda, and I Jinnai, and H Mizuno, and T Sakata, and S Kusumoto, and H Kayano, and H Takeuchi, and M Bessho, and M Saito, and I Katayama
First Department of Internal Medicine, Saitama Medical School.

A 45-year-old male was hospitalized on September 2, 1989 with chief complaints of general fatigue and fever. Physical examination revealed hepatomegaly and massive splenomegaly. Laboratory tests on admission showed Hb of 7.5g/dl, PLT 4.8 x 10(4)/microliters and WBC 9,610/microliters with 81% hairy cells. Bone marrow aspirate demonstrated 55.1% hairy cells and moderate myelofibrosis. Cytochemically, hairy cells were positive for tartrate-resistant acid phosphatase (TRAP). Surface markers were SmIg G+ A+ kappa +, CD11b+, CD11c+, CD19+, CD20+, CD21-, CD25+, HC2+, HLA-DR+. From these findings, a diagnosis of hairy cell leukemia (HCL) was made. After administration of deoxycoformycin (DCF) at a dose of 5.0mg/m2 1-2 times monthly, splenomegaly disappeared, as did hairy cells from the peripheral blood. Hematological level returned to within normal range except for the presence of 1.2% hairy cells and mild myelofibrosis in bone marrow aspirates. DCF has so far been effective for this patient. While DCF has been reported to be effective in the treatment of HCL in the West, it has not been determined in Japanese patients with HCL, who have different hematologic features from those of HCL patients in the West.

UI MeSH Term Description Entries
D007943 Leukemia, Hairy Cell A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of "hairy" or "flagellated" cells in the blood and bone marrow. Hairy Cell Leukemia,Leukemic Reticuloendotheliosis,Reticuloendotheliosis, Leukemic,Hairy Cell Leukemias,Leukemias, Hairy Cell,Leukemic Reticuloendothelioses,Reticuloendothelioses, Leukemic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015649 Pentostatin A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity. 2'-Deoxycoformycin,CI-825,Co-Vidarabine,Deoxycoformycin,Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-,NSC-218321,Nipent,2' Deoxycoformycin,CI 825,CI825,NSC 218321,NSC218321

Related Publications

A Matsuda, and I Jinnai, and H Mizuno, and T Sakata, and S Kusumoto, and H Kayano, and H Takeuchi, and M Bessho, and M Saito, and I Katayama
May 2001, [Rinsho ketsueki] The Japanese journal of clinical hematology,
A Matsuda, and I Jinnai, and H Mizuno, and T Sakata, and S Kusumoto, and H Kayano, and H Takeuchi, and M Bessho, and M Saito, and I Katayama
February 1992, [Rinsho ketsueki] The Japanese journal of clinical hematology,
A Matsuda, and I Jinnai, and H Mizuno, and T Sakata, and S Kusumoto, and H Kayano, and H Takeuchi, and M Bessho, and M Saito, and I Katayama
May 2004, [Rinsho ketsueki] The Japanese journal of clinical hematology,
A Matsuda, and I Jinnai, and H Mizuno, and T Sakata, and S Kusumoto, and H Kayano, and H Takeuchi, and M Bessho, and M Saito, and I Katayama
April 1987, The New England journal of medicine,
A Matsuda, and I Jinnai, and H Mizuno, and T Sakata, and S Kusumoto, and H Kayano, and H Takeuchi, and M Bessho, and M Saito, and I Katayama
January 1989, Blood,
A Matsuda, and I Jinnai, and H Mizuno, and T Sakata, and S Kusumoto, and H Kayano, and H Takeuchi, and M Bessho, and M Saito, and I Katayama
June 2002, Leukemia & lymphoma,
A Matsuda, and I Jinnai, and H Mizuno, and T Sakata, and S Kusumoto, and H Kayano, and H Takeuchi, and M Bessho, and M Saito, and I Katayama
January 1994, Leukemia & lymphoma,
A Matsuda, and I Jinnai, and H Mizuno, and T Sakata, and S Kusumoto, and H Kayano, and H Takeuchi, and M Bessho, and M Saito, and I Katayama
December 1992, Japanese journal of clinical oncology,
A Matsuda, and I Jinnai, and H Mizuno, and T Sakata, and S Kusumoto, and H Kayano, and H Takeuchi, and M Bessho, and M Saito, and I Katayama
July 2002, [Rinsho ketsueki] The Japanese journal of clinical hematology,
A Matsuda, and I Jinnai, and H Mizuno, and T Sakata, and S Kusumoto, and H Kayano, and H Takeuchi, and M Bessho, and M Saito, and I Katayama
December 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!